Taylor Tate Deborah 4

What Happened Deborah Taylor Tate, a director of HealthStream, was granted 3,654 restricted stock units (RSUs) on May 28, 2026. The grant is reported as a derivative award at $0.00 per unit (no cash paid). RSUs represent the right to receive one share of common stock upon vesting.

Key Details

• Transaction date: May 28, 2026; Form 4 filed June 1, 2026 (timely within required business days).
• Grant type/code: Award/Grant (derivative RSUs), 3,654 units, reported price $0.00.
• Vesting: Three-year schedule, contingent on continued service; vests annually in three equal installments beginning May 28, 2027 (per filing footnotes).
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes: F1 = each RSU equals one share upon vesting; F2 = three-year, annual vesting beginning 5/28/2027; F3 = not applicable.

Context This is a typical executive/director equity award meant to align long-term interests with shareholders; RSUs do not result in current share ownership until they vest and are not an immediate market purchase or sale. Such grants are routine compensation and do not by themselves indicate a buy/sell market signal.